The Medical Practitioners’ Challenge in 2001: Informed, Accurate Diagnosis


Since 1996, the CDC’s National Centre for Infectious Diseases has defined ME/CFS as a Priority #1 Disease of Public Health importance. Prevalence estimate is 183 people per 100,000 population.

How does the hurried medical practitioner reach an accurate diagnosis of ME/CFS when faced with multiple symptoms, non specific pathology and little time to document a long, complex history? Superficial evaluation frequently leads to misdiagnoses such as depression, anxiety or somatoform disorder.

This challenging meeting of international and Australian researchers and clinicians will present the latest findings to assist differential diagnosis and advance clinical care.


Anthony Komaroff

Professor of Medicine, Harvard Medical School, Cambridge, MA

-Director of the Division of General Medicine and Primary Care

-Established one of US’s premier academic units

-Has an active research program in CFS regarding chronic post-infectious fatigue syndromes

-Performs a significant role in the reinvigorated CDC CFS Program

Wilhelmena Behan

Professor of Pathology, Glasgow University, Glasgow, UK

– Directs a leading neuroscience research program to elucidate the pathogenesis of CFS, in collaboration with eminent scientists in neurology, nuclear medicine, exercise science and medicine, and molecular genetics – First to describe mitochondrial dysfunction in CFS

Garth Nicolson

Chief Scientific Officer, Institute for Molecular Medicine, Huntington Beach, USA

– Is among world’s most-cited scientists in field of pathology and cancer biology

– Has particular interest in role of chronic infections in chronic illnesses including CFS, FM, Gulf War Illness, RA

– Is developing diagnostic procedures using Nucleoprotein Gene Tracking and Forensic Polymerase Chain Reaction-Hybridization

Kenny De Meirleir

Professor of Medicine and Physiology, Free University of Brussels, Belgium

– Since 1990, has established a CFS Program researching autonomic function, exercise physiology, RNaseL pathway

– Is researching pathophysiological mechanisms and potential role of acquired channelopathy


Saturday, 1 December 2001, Day 1

7.45am Registration

8.45am Welcome

9.00am Opening Address, Presentations

5.00pm Close Day 1

Sunday, 2 December 2001, Day 2

8.30am Presentations

3.00pm Close

The aetiology, pathophysiology, and management of ME/CFS will be explored.


diagnostic criteria

orthostatic intolerance/autonomic dysfunction

immune abnormalities

neuroendocrine and other biochemical abnormalities

acquired channelopathy

neurocognitive impairment

gastrointestinal dysfunction

exercise intolerance

impaired sleep cycle

environmental exposures


neuropsychiatric manifestations

differentiating ME/CFS from psychiatric disorder

Presentations and Posters will include:

evidence of persistent infection

evidence of cardiovascular impairment

SPECT findings of hypoperfusion in limbic system and brain stem

exploration of molecular mechanisms in exercise intolerance

gastric emptying studies demonstrating abnormal gut motility

Case Studies

Panel discussions around management issues will be interspersed throughout the program.


Secretariat C. Hunter – A. Leggo – J. Jolly


Click on the link below to go to the printable conference registration form:


For bookings:

Manly Pacific Parkroyal Hotel (4 Star) – (Venue)

Telephone: +61 2 9977 7666

Manly View $191 per room per night; Ocean View $233 per room per night

Manly Paradise Motel (3 Star) – (2 minutes walk)

Telephone: +61 2 9977 5799

From $150 per night/minimum stay 2 nights

Accommodation is NOT included in registration fee.


Manly Pacific Parkroyal Hotel

55 North Steyne, Manly

Sydney, Australia

Telephone: +61 2 9977 7666

Facsimile: +61 2 9977 7822


Registration desk located in foyer on level 1, Manly Pacific Parkroyal Hotel. Car parking is available at the venue at a rate of $11 per day.

1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)

1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)

Leave a Reply